I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Afatinib and Dacomitinib Efficacy, Safety, Progression Patt..:
Hong-Shuai Li
;
Shou-Zheng Wang
;
Hai-Yan Xu
...
https://www.mdpi.com/2072-6694/14/21/5307. , 2022
Link:
https://doi.org/10.3390/cancers14215307
RT Journal T1
Afatinib and Dacomitinib Efficacy, Safety, Progression Patterns, and Resistance Mechanisms in Patients with Non-Small Cell Lung Cancer Carrying Uncommon EGFR Mutations: A Comparative Cohort Study in China (AFANDA Study)
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:82016500f9904e9695ac1fc866f40beb&Exemplar=1&LAN=DE A1 Hong-Shuai Li A1 Shou-Zheng Wang A1 Hai-Yan Xu A1 Xiang Yan A1 Jin-Yao Zhang A1 Si-Yu Lei A1 Teng Li A1 Xue-Zhi Hao A1 Tao Zhang A1 Guang-Jian Yang A1 Li-Qiang Zhou A1 Peng Liu A1 Yu-Ying Wang A1 Xing-Sheng Hu A1 Pu-Yuan Xing A1 Yan Wang PB MDPI AG YR 2022 K1 non-small cell lung cancer K1 dacomitinib K1 afatinib K1 uncommon EGFR mutations K1 efficacy K1 safety K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.mdpi.com/2072-6694/14/21/5307 LK http://dx.doi.org/https://doi.org/10.3390/cancers14215307 DO https://doi.org/10.3390/cancers14215307 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)